Trial Profile
Safety and efficacy of SCH 417690 in HIV-infected treatment-naive subjects
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 12 Oct 2020
Price :
$35
*
At a glance
- Drugs Vicriviroc (Primary) ; Efavirenz; Lamivudine/zidovudine
- Indications HIV infections
- Focus Therapeutic Use
- Sponsors Schering-Plough
- 10 Oct 2020 Status changed from discontinued to completed.
- 10 Oct 2020 Status changed from discontinued to completed.
- 05 Nov 2010 New trial record.